Bibliography
- HAZUDA DJ, FELOCK P, WITMER M et al.: Inhibitors of strand transfer that prevent integration and inhibit HIV- 1 replication in cells. Science (2000) 287:646–650.
- ••An important paper validating HIV-1integrase as a target of a series of diketo acid-containing compounds.
- YOSHINAGA T, SATO A, FUJISHITA T, FUJI WARA T: In vitro activity of a new HIV-1 integrase inhibitor in clinical development. 9th Conference on Retro viruses and Opportunistic Infections, Seattle, USA (2002).
- NEAMATI N: Patented small molecule inhibitors of HIV-1 integrase: a ten-year saga. Expert Opirr. Ther. Pat. (2002) 12:709–724.
- ••The first review of the entire patentliterature covering the small-molecule inhibitors of HIV-1 integrase for the years 1992-2002.
- NEAMATI N, BARCHI JJ Jr: New paradigms in drug design and discovery. Cum: Top. Med. Chem. (2002) 2:211–227.
- NEAMATI N: Structure-based HIV-1 integrase inhibitor design: a future perspective. Expert Opirr. Invest. Drugs (2001) 10:281–296.
- NEAMATI N, MARCHAND C, POMMIER Y: HIV-1 integrase inhibitors: past, present, and future. Adv. Pharmacol. (2000) 49:147–165.
- CHEN IJ, NEAMATI N, MACKERELL AD jr: Structure-based inhibitor design targeting HIV-1 integrase. Cum: Drug Targets Infect. Disord. (2002) 2:217–234.
- ESTE JA, CABRERA C, SCHOLS D etal.: Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). Md. Pharmacol. (1998) 53:340–345.
- PLUYMERS W, NEAMATI N, PANNECOUQUE C et al.: Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. Md. Pharmacol. (2000) 58:641–648.
- MAZUMDER A, GAZIT A, LEVITZKI A etal.: Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus Type 1 integrase. Biochemistry (1995) 34:15111–15122.
- NEAMATI N, HONG H, OWEN JM et al.: Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. j Med. Chem. (1998) 41:3202–3209.
- ESPESETH AS, FELOCK P, WOLFE A et al.: HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc. Natl. Acad. Sri. USA (2000) 97:11244–11249.
- •This paper describes that a selected diketo acid-containing inhibitor competes with target DNA and provides evidence that a conformation of integrase that is only adopted after assembly is important for drug binding.
- MARCHAND C, ZHANG X, PATS GC et al.: Structural determinants for HIV-1 integrase inhibition by beta-diketo acids. _J. Biol. Chem. (2002) 277:12596–12603.
- NEAMATI N, MAZUMDER A, ZHAO H et al.: Diarylsulfones, a novel class of human immunodeficiency virus Type 1 integrase inhibitors. Antimicrob. Agents Chemother. (1997) 41:385–393.
- ••This paper describes a series of sulfonesand a mercaptobenzene sulfone as inhibitors of HIV-1 integrase.
- NEAMATI N, MAZUMDER A, SUNDERS etal.: 2-Mercaptobenzenesulfonamides as novel class of human immunodeficiency Type 1 (HIV-1) integrase and HIV-1 replication. Antimicrob. Agents Chemother. (1997) 8:485–495.
- ••The first report of mercaptobenzenecontaining inhibitors of HIV-1 integrase.
- NEAMATI N, UN Z, KARKI RG etal.: Metal-dependent inhibition of HIV-1 integrase. _J. Med. Chem. (2002) 45:5661–5670.
- •An important paper describing the role ofdivalent metals and cysteine 65 for binding of the mercaptosalicylhydrazides on the active site of HIV-1 integrase.